Naphyrone

Naphyrone, also known as O-2482 and naphthylpyrovalerone, is a type of stimulant that is part of the naphthylisoquinoline class. It was initially developed in the 1960s by a team at Boehringer Ingelheim. Naphyrone came into the public eye in the late 2000s for its use as an ingredient in a number of designer drugs sold as "bath salts" or "plant food".

Chemistry

Naphyrone is a naphthylisoquinoline derivative, closely related to other drugs such as pyrovalerone, MDPV, and prolintane. It is a pure norepinephrine-dopamine reuptake inhibitor (NDRI) with virtually no serotonin action.

Effects

Naphyrone's effects are primarily caused by its activity as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is known to increase the levels of these two neurotransmitters in the brain by inhibiting their reuptake. This can lead to increased alertness, feelings of euphoria, increased motivation, and increased sociability.

Legal Status

Naphyrone has been classified as a Class B drug in the United Kingdom under the Misuse of Drugs Act 1971, making it illegal to sell, buy, or possess without a license. It has also been banned in a number of other countries, including the United States, Australia, and New Zealand.

Health Risks

The use of naphyrone can lead to a number of health risks, including heart problems, psychosis, and severe addiction. It can also cause a number of unpleasant side effects, such as anxiety, paranoia, and insomnia.

See Also

• Designer drug
• Stimulant
• Norepinephrine-dopamine reuptake inhibitor

Error creating thumbnail: This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

Naphyrone

• File:Naphyrone.svg
• File:Alpha-naphyrone.svg